World Pharma News Digest - 07.03.2008

World Pharma News Digest - 07.03.2008

DAIICHI SANKYO acquires osteoporosis medication EVISTA(R) from Lilly
The Japanese pharmaceutical company DAIICHI SANKYO Group has purchased
the European rights to the osteoporosis medication EVISTA(R) from the
U.S. Company Eli Lilly and Company. In the process, the company is
planning to gain additional sales volume of approximately EURO 80
million.
Read more...
* w w w .worldpharmanews . com /content/view/325/1/

Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
Genzyme Corp. (Nasdaq: GENZ) announced the U.S. launch of the
phosphate binder Renvela(R) (sevelamer carbonate) for dialysis patients,
as well as significant progress in its international efforts to secure
additional approvals for the product. Genzyme has submitted a
marketing authorization application to the European Medicines Agency
seeking approval of Renvela for the control of serum phosphorus in
chronic kidney disease patients regardless of whether they are on
dialysis.
Read more...
* w w w .worldpharmanews . com /content/view/324/1/

Forty Pharmaceutical Speakers Announced for the Pharma CI Conference
in New Jersey
An unprecedented 40 senior level pharma speakers to headline the 2008
Pharma Competitive Intelligence (CI) Conference on Sept. 15-17 in New
Jersey. This is one of the best and largest gathering of pharma CI/BI
professionals. The Pharma CI Conference is widely attended by a large
variety of executives from large, medium-sized, and smaller
pharmaceutical and biotechnology companies.
Read more...
* w w w .worldpharmanews . com /content/view/323/1/

Pfizer Presents New Opportunities for Global Growth
Pfizer Inc. reviewed strategies to accelerate and refocus Pfizer's
pipeline and capture new opportunities for global growth at a meeting
for investment analysts. "We have made real changes in how we operate
our business - in our structure, culture and leadership - so that we
have a much stronger foundation in place for pursuing the many
opportunities before us," said Chairman and CEO Jeff Kindler.
Read more...
* w w w .worldpharmanews . com /content/view/322/1/

FDA grants Priority Review For Promacta/Revolade (Eltrombopag)
GlaxoSmithKline announced that the United States Food and Drug
Administration (FDA) has granted Priority Review for Promacta(R)/
Revolade(R) (eltrombopag) for the short-term treatment of patients with
chronic idiopathic thrombocytopenic purpura (ITP).
Read more...
* w w w .worldpharmanews . com /content/view/321/1/

Court decides against Bayer's Yasmin(R) patent
US District Court for the District of New Jersey ruled against the
validity of Bayer Schering Pharma's 531 patent for the company's oral
contraceptive Yasmin, the result of a patent challenge by generic
manufacturer Barr Laboratories. Bayer disagrees with the court's
decision and will consider its legal options in this regard. The
company will continue to vigorously defend its intellectual property.
Read more...
* w w w .worldpharmanews . com /content/view/320/1/

Tattooing is a more effective way of administering DNA vaccines than
direct injection
Tattooing is a more effective way of administering DNA vaccines than
direct injection into muscle tissue, according to new research by
German and Czech scientists. In DNA vaccination, a gene from a
pathogen is injected directly into the host, which then produces the
corresponding pathogen protein inside its own cells. This triggers a
response from the host's immune system. Advantages of DNA vaccination
include the fact that the vectors can be constructed quickly, and
rapid and large scale vaccine production is much cheaper than for
traditional vaccines.
Read more...
* w w w .worldpharmanews . com /content/view/319/1/

World Pharma News . net / Published News:

A Day of Shame for Science in the United Kingdom
* w w w .worldpharmanews . net /ClinicalTrials/A Day of Shame for Science in the United Kingdom-1/

Forty Pharmaceutical Speakers Announced for the Pharma CI Conference
in New Jersey
* w w w .worldpharmanews . net /Conferences Events/Forty Pharmaceutical Speakers Announced for the Pharma CI Conference in New Jersey/

Drug Injury Watch: Sprint Fidelis Recall Showed That FDA's Medical
Device Safety System Is Flawed
* w w w .worldpharmanews . net /Blogs/Drug Injury Watch Sprint Fidelis Recall Showed That FDAs Medical Device Safety System Is Flawed/

Pfizer Analyst Day: The Analysts React - Pharmas Market with Mike
Huckman - MSNBC . com
* w w w .worldpharmanews . net /Financial/Pfizer Analyst Day The Analysts React - Pharmas Market with Mike Huckman - MSNBC-com/

Pharmalot Glaxo Escapes Prosecution Over Paxil In UK
* w w w .worldpharmanews . net /Product/Pharmalot - Glaxo Escapes Prosecution Over Paxil In UK/

The Great Glut of Health 2.0 - Medgadget
* w w w .worldpharmanews . net /Blogs/The Great Glut of Health 2-0 - Medgadget/

Pfizer Presents New Opportunities for Global Growth
* w w w .worldpharmanews . net /Corporate/Pfizer Presents New Opportunities for Global Growth/

Patient Lawsuits Against Pharmacuetical Companies For Drug Injuries
Might Be Prohibited In U.S.
* w w w .worldpharmanews . net /Blogs/Patient Lawsuits Against Pharmacuetical Companies For Drug Injuries Might Be Prohibited In U-S-/

Bacteria, Eating Snow and Climate Change : Bio Job Blog
* w w w .worldpharmanews . net /Blogs/Bacteria Eating Snow and Climate Change Bio Job Blog/

Study: Post-menopause hormone pills linked to cancer - USATODAY . com
* w w w .worldpharmanews . net /Research Development/Study Post-menopause hormone pills linked to cancer - USATODAY-com/